Cheyenne, Wyoming , June 01, 2016 (GLOBE NEWSWIRE) -- MedX Holdings, Inc. (OTC PINK: MEDH) today announces that we have identified three viable options in the Mobile Alabama area for a turnkey warehouse/office space with plans to make a formal offer on one of the three locations by Monday, June 6th. This represents a major accomplishment for us. Once the offer is accepted we can then file for a license to become officially a Licensed Manufacture/Wholesale Distributor in the state of Alabama. Our license will be held under the name MedX Pharmaceuticals, Inc. a Alabama Corporation which will be structured as a wholly-owned subsidiary of MedX Holdings, Inc. Mr. Yelton, our Certified Designated Representative will sit on the Board of Directors for MedX Pharmaceuticals, Inc.
Ms. Roberton, CEO commented: “Once we are licensed in the state of Alabama, we can legally purchase drugs, repackagle them if we desire and ultimately ship these products to our clients. We have currently identified over 200 pharmacies in the state of Alabama and Kentucky as immediate potential clients.
Moving forward, it is the goal of MEDH to become and remain very transparent with our shareholders. As a result, it is our commitment to put out market updates anytime anything news worthy occurs.
MedX Holdings, Inc. is a publicly trading holding company utilizing a new form of Collaborative Governance. MEDH targets the acquisitions of undervalued, turnaround medical related businesses. In addition, MEDH is newly emerging as dynamic distributor of pharmaceutical products.
For more information about MedX Holdings, Inc., call (877) 225-0243 or visit our web site www.medxholdings.com is located at 1621 Central Avenue, Cheyenne, WY, USA
Safe-Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company’s financing plans; (ii) trends affecting the company’s financial condition or results of operations; (iii) the company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company’s Forms 10-K and 10-Q filed with the SEC.
Source:MedX Holdings, Inc.